GRK2 and breast carcinoma: No association of ELAVL1 and ADRBK1 co-expression was evidenced with the molecular subtypes of breast cancer “basal-like”, “normal-like” or “HER2-enriched” in the three independent cohorts, whereas a significant direct correlation was noted in the luminal subtype (Figure S6C).